Feburic generics acquired additional sales approvals

Generic development of Feburic Tab(febuxostat), a gout treatment, has been fueled.

The Ministry of Food and Drug Safety(MFDS) decided prohibition of its generic sales by the request of the patentee(the original company), but domestic pharmaceutical companies are planning to launch them through patent challenge after acquiring product approvals.

On the 30^th, the MFDS approved sales of Feburic ...